Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Dominguez-Rodriguez

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|January 21, 2026
Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trialXavier Rossello, José A Barrabés, Massimo Piepoli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trialXavier Rossello, Pedro L Sánchez, Ruth Owen, et al.
European Heart Journal|August 30, 2025
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trialXavier Rossello, Alberto Dominguez-Rodriguez, Roberto Latini, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 1, 2022
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter RegistryMichele Millesimo, Edoardo Elia, Giorgio Marengo, et al.
European Heart Journal. Acute Cardiovascular Care|October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMIFederico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
European Heart Journal. Cardiovascular Pharmacotherapy|January 21, 2026
Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trialXavier Rossello, José A Barrabés, Massimo Piepoli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trialXavier Rossello, Pedro L Sánchez, Ruth Owen, et al.
European Heart Journal|August 30, 2025
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trialXavier Rossello, Alberto Dominguez-Rodriguez, Roberto Latini, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 1, 2022
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter RegistryMichele Millesimo, Edoardo Elia, Giorgio Marengo, et al.
European Heart Journal. Acute Cardiovascular Care|October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMIFederico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Pageof 17